Immuno-dermatology company Alys Pharmaceuticals has launched with an R&D pipeline enabled by multiple platform technologies and a $100 million financing by heal 12 February 2024
Two Californian firms, Gilead Sciences and Arcus Biosciences, have doubled down on their commitment to developing new therapies using the TIGIT pathway. 30 January 2024